HollandThomas

A team of Duke Health clinicians that include faculty from the Department of Medicine are working diligently in a collaborative effort to enroll patients in a randomized, controlled trial, testing a novel antibody treatment for COVID-19.

Dr. Thomas Holland is an author of two recent publications in high-impact journals - one in Clinical Infectious Diseases and another, an editorial, in The Lancet 

Thomas Holland, MD, medical instructor in the Division of Infectious Diseases and ho

Thomas Holland, MD, medical instructor in the Division of Infectious Diseases and ho

Subscribe to HollandThomas